Aprea Therapeutics
Price & Volume
Stats
See more52W Range | $0.41-$1.38 |
Market Cap | $6.1M |
Shares Short | 621,151 |
Financials
See moreRevenue (12 Mos) | $5,185 |
Revenue Growth (YoY) | -98.4% |
Gross Profit (12 Mos) | -$6.7M |
Diluted EPS | -$0.95 |
News
See moreYahoo Finance • 3 months ago
Aprea Advances APR-1051; Phase 1 Enrollment Accelerates
Yahoo Finance • 3 months ago
Lipocine Appoints Michael J. Grissinger to Board of Directors
Yahoo Finance • 4 months ago
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
Yahoo Finance • 6 months ago
Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
About
CEO | Dr. Oren Gilad Ph.D. |
CFO | Mr. John P. Hamill CPA |
Address | 3805 Old Easton Road, Doylestown, PA, United States, 18902 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |